cefdinir + trimethoprim + sulfamethoxazole

This is a combination of three antibiotics—cefdinir, trimethoprim, and sulfamethoxazole. Cefdinir is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death. Trimethoprim is a dihydrofolate reductase inhibitor that blocks the reduction of dihydrofolic acid to tetrahydrofolic acid, interfering with bacterial DNA synthesis. Sulfamethoxazole is a sulfonamide antibiotic that inhibits dihydropteroate synthase in the folic acid pathway, also disrupting DNA synthesis. The combination of trimethoprim and sulfamethoxazole (commonly known as co-trimoxazole or Bactrim) acts synergistically by inhibiting sequential steps in folate metabolism; cefdinir provides additional coverage against susceptible Gram-positive and Gram-negative bacteria through its distinct mechanism[1][6][7][9]. This triple combination would theoretically provide broad-spectrum antibacterial activity but is not an established or standard formulation.